Ovary Removal May Play a
Role in Lung Cancer
A new Canadian study reports that castration (removal of the female gonads, the ovaries) almost doubles a younger woman’s risk for developing lung cancer. “It’s possible that vulnerability to lung cancer is caused by early and sudden decrease in estrogen levels or potentially long-term use of hormone replacement therapy, and further research is needed to explore these hypotheses.” said study co-author Jack Siemiatycki, a professor at the University of Montreal’s Department of Social and Preventive Medicine.
The report was published online in the International Journal of Cancer in May 2009. It is based on a study of 999 patients from hospitals in Montreal including 422 women with lung cancer. “A major strength of this study was the detailed smoking information which we obtained from all study participants,” said study co-author Anita Koushik. “This is important because of the role of smoking in lung cancer and because smokers generally have lower estrogen levels than non-smokers.”
“Although smoking is the dominant cause of lung cancer, we know other factors can play an important role in enhancing the impact of tobacco carcinogens.” Koushik added “This research suggests that, in women, hormonal factors may play such a role.”
A note from Nora W. Coffey
This important discovery should alert every woman and man to the fact that removal of the female organs creates a higher risk of life threatening health problems including but not limited to heart disease, stroke, dementia and lung cancer. Although not considered a “health” or life threatening problem, the loss of sexual feeling and loss of vitality associated with sexual energy are serious adverse effects of hysterectomy and/or castration. There are many more permanent consequences that have either not been discovered, or if known, they have been denied or not reported.